스타필로코커스 호미니스 MBBL2-9 로부터 생산되는 신규한 항균 펩타이드 호미니신 및 유도체
    1.
    发明授权
    스타필로코커스 호미니스 MBBL2-9 로부터 생산되는 신규한 항균 펩타이드 호미니신 및 유도체 有权
    一种新型抗生素肽HOMINICIN及其衍生物,来自印第安人类生物学MBBL 2-9

    公开(公告)号:KR100968080B1

    公开(公告)日:2010-07-08

    申请号:KR1020090071732

    申请日:2009-08-04

    Abstract: PURPOSE: A Staphylococcus hominis MBBL 2-9 strain is provided to ensure antibacterial activity to bacteria and to prevent gram positive/antibiotics resistant pathogen. CONSTITUTION: An antibacterial peptide hominicin which is isolated from Staphylococcus hominis MBBL 2-9 has an amino acid of sequence number 1. The antibacterial peptide is themal resistant, acid resistant, basic resistant, and non-cytotoxicity. The antibacterial peptide contains DmIle(N1, N1-dimethyl isoleucine), Dhb(dehydrobutyrine), and Dmp(N2, N2-dimethyl-1,2-propanediamine). A medicinal composition for preventing gram positive pathogen or antibiotics resistant pathogen contains the antibacterial peptide as an active ingredient.

    Abstract translation: 目的:提供人类葡萄球菌MBBL 2-9菌株,以确保对细菌的抗菌活性,并防止革兰氏阳性/抗生素抗性病原体。 构成:从人类金黄色葡萄球菌MBBL 2-9中分离得到的抗菌肽人参皂苷具有序列号1的氨基酸。抗菌肽具有抗药性,耐酸碱性,无细胞毒性。 抗菌肽含有DmIle(N1,N1-二甲基异亮氨酸),Dhb(脱氢丁内酯)和Dmp(N 2,N 2 - 二甲基-1,2-丙二胺)。 用于预防革兰氏阳性病原体或抗生素抗性病原体的药物组合物含有抗菌肽作为活性成分。

Patent Agency Ranking